Sarepta establishes 2026 Equity Incentive Plan with 6.74M share pool
Sarepta Therapeutics adopted a new equity incentive plan authorizing 6.74 million shares for stock and stock-based awards to employees and participants. The plan replaces prior equity plans and includes standard provisions for stock options, SARs, and other equity awards with adm
View filing at SEC.gov →